Kai Yao

7PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical mycologyMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2026
Antibody-drug conjugate-related marker heterogeneity between primary tumors and metastatic lymph nodes in advanced urothelial cancers.

|Feb 23, 2026
PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer.

Ruilin Zhuang, Qianghua Zhou, Bisheng Cheng

|Dec 07, 2025
NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer.

Yi Tang, Xinpei Deng, Yanjun Wang

|Sep 10, 2024
Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer.

Jing Han, Min Lin, Qingguang Lin

|Sep 23, 2022
miR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1/MMP2/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma.

Xingliang Tan, Zhenhua Liu, Yanjun Wang

|Jul 06, 2022
Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study.

Leiwen Fu, Tian Tian, Kai Yao

Pageof 2

Frequent Collaborators

3 joint publications

Xingliang Tan

1 joint publications

Leiwen Fu

1 joint publications

Tian Tian

1 joint publications

Xiang-Feng Chen